Soluble Ab oligomers contribute importantly to synaptotoxicity in Alzheimer's disease, but their dynamics in vivo remain unclear. Here, we found that soluble Ab oligomers were sequestered from brain interstitial fluid onto brain membranes much more rapidly than nontoxic monomers and were recovered in part as bound to GM1 ganglioside on membranes. Ab oligomers bound strongly to GM1 ganglioside, and blocking the sialic acid residue on GM1 decreased oligomer-mediated LTP impairment in mouse hippocampal slices. In a hAPP transgenic mouse model, substantial levels of GM1-bound Ab 42 were recovered from brain membrane fractions. We also detected GM1-bound Ab in human CSF, and its levels correlated with Ab 42 , suggesting its potential as a biomarker of Ab-related membrane dysfunction. Together, these findings highlight a mechanism whereby hydrophobic Ab oligomers become sequestered onto GM1 ganglioside and presumably other lipids on neuronal membranes, where they may induce progressive functional and structural changes.
INTRODUCTION
The most prevalent neurodegenerative disorder, Alzheimer's disease (AD), impairs episodic declarative memory and executive function early in its clinical phase. Enhanced synapse loss, particularly in the temporal and frontal cortices, helps distinguish AD from normal brain aging (West et al., 1994) and serves as a strong correlate of cognitive decline (Terry et al., 1991) . Research in many laboratories has provided extensive evidence that AD is initially a disorder of selected synapses in which soluble, low molecular weight (LMW) oligomers of amyloid b-protein (Ab) can act as prime synaptotoxic agents (reviewed in Mucke and Selkoe, 2012) . In one example, mice expressing an APP mutation that causes AD in humans underwent rapid formation and stabilization of Ab oligomers accompanied by profound synaptic and neuronal loss in the absence of fibrillar amyloid plaques in the cortex (Tomiyama et al., 2010) . In light of numerous such studies implicating a pathogenic role of soluble Ab oligomers and the evidence that lowered Ab 42 monomer levels in cerebrospinal fluid (CSF) represents the earliest biomarker for AD (Bateman et al., 2012; Craig-Schapiro et al., 2009; Fagan et al., 2009; Golde et al., 2011; Morris and Selkoe, 2011) , the search for such oligomers in biological fluids, primarily in human CSF, has intensified in recent years (Benilova et al., 2012) . The recent report that a phase 3 trial of the Ab-specific monoclonal antibody solanezumab produced a small but significant cognitive benefit in patients with mild AD (Doody, 2012, ANA, conference) has made it even more critical to understand the earliest changes in the economy of synaptotoxic Ab oligomers in the brain and biological fluids. A few reports of the detection of apparent Ab oligomers in CSF and plasma have appeared (Fukumoto et al., 2010; Gao et al., 2010; Klyubin et al., 2008; Villemagne et al., 2010) ; however, the interpretation of these reports has been clouded by failure to define the precise oligomeric unit the assays are detecting, an inability to exclude definitively the detection of Ab monomers, and, in some cases, the lack of validating the assays on natural oligomers in biological samples.
In this context, we have systematically examined the steadystate levels of LMW Ab oligomers in aqueous compartments of the CNS, i.e., the brain interstitial fluid (ISF) and CSF of a wellcharacterized mouse model of AD, the J20 hAPP transgenic (tg) line (Mucke et al., 2000) . While we readily detected monomers, we failed to detect any substantial levels of LMW (<35 kDa) Ab oligomers in the CNS fluid compartment using several biochemical methods. We then hypothesized that due to their increased hydrophobicity, Ab oligomers may bind to cell membranes, preexisting Ab aggregates (in plaque-containing brains), or other hydrophobic surfaces much more rapidly than monomers do. If so, this could help clarify potential mechanisms behind observations that Ab oligomers, but not monomers, can exert synaptotoxicity (Gong et al., 2003; Klyubin et al., 2005; Lacor et al., 2004; Lambert et al., 1998; Lesné et al., 2006; Shankar et al., 2007 Shankar et al., , 2008 Walsh et al., 2002) , alter tau and other cytoskeletal proteins (Gö tz et al., 2001; Jin et al., 2011; Lewis et al., 2001; Oddo et al., 2004; Zempel et al., 2010) , and induce other cytotoxic effects. To address this concept, we quantified the in vivo half-life of microinjected Ab dimers versus monomers in the ISF of healthy, wild-type (WT) mice using microdialysis and ISF injections of synthetic Ab dimers and natural oligomers isolated from human (AD) brain tissue. We followed the fate of the microinjected Ab and found that most of it became tightly bound to endogenous GM1 ganglioside on membrane extracts of the brains. In vitro binding assays indicated that Ab dimers bind to GM1 ganglioside much more strongly than monomers. Masking the sialic acid residue on GM1 decreased Ab oligomer-mediated LTP inhibition in WT mouse hippocampal slices. Next, we examined brain membrane extracts of J20 tg mice prior to plaque formation and recovered a significantly higher level of endogenous Ab 42 than Ab 40 complexed with GM1. The levels of GM1-Ab complexes obtained from brain membrane extracts were proportional to the levels of diffusible ISF Ab in young tg mice, suggesting that the formation of the GM1-Ab complexes may be a dynamic equilibrium. Finally, using a sensitive immunoprecipitation (IP) technique, we discovered low levels of GM1-bound Ab directly in human CSF, and its levels correlated significantly with the CSF levels of Ab 42 . The implications of these findings for understanding the dynamic economy of soluble Ab oligomers in the brain are discussed.
RESULTS

Steady-State Levels of LMW Ab Oligomers in CNS Fluids
Are Very Low or Undetectable We initially assessed the levels of soluble Ab oligomers in the hippocampal ISF and CSF. We define Ab oligomers here as soluble LMW oligomers (dimers, trimers, tetramers, etc.) that remain in the supernatant after high speed ultracentrifugation, as opposed to high molecular weight, prefibrillar Ab aggregates that can often be pelleted by ultracentrifugation. To obtain hippocampal ISF, we performed in vivo microdialysis in awake, behaving J20 tg mice using microdialysis rates (0.2-0.4 ml/min) low enough to allow ready recovery of soluble Ab (Cirrito et al., 2003; Hong et al., 2011) . CSF was collected from the cisterna magna of anesthetized J20 mice (DeMattos et al., 2002) , a method that, in contrast to microdialysis, does not limit the recovery of soluble molecules according to their size. Anti-Ab immunoprecipitates of hippocampal ISF and CSF yielded the 4 kDa monomer and a 5 kDa Ab-immunoreactive band migrating just above it but no SDS-stable Ab dimers (which run at 6.5 kDa in these gels) (Figures 1A and S1A available online) . This apparent lack of Ab oligomers in both tg ISF and CSF was not due to an inability of our two polyclonal Ab antisera (AW8 [Hong et al., 2011] or R1282 [Podlisny et al., 1998 ]) to immunoprecipitate oligomers, as each effectively pulled down both the endogenous Ab dimers present in Tris-buffered saline (TBS) extracts of 20-month-old tg mouse brains and the synthetic WT Ab and disulfide-crosslinked (Ab 1-40 S26C) 2 dimers (Shankar et al., 2008) (Figures 1A, S1A , and S1B).
Next, we used a recently developed Ab oligomer-ELISA (o-ELISA) that specifically recognizes natural Ab oligomers of a wide range of sizes (dimers up to prefibrillar soluble oligomers), but not Ab monomers, and detects small amounts (sensitivity % 6 pg/ml) of both synthetic and natural Ab oligomers isolated from AD cortex . However, the o-ELISA failed to detect any Ab oligomer signal in 3-and 20-month-old tg ISF or 3-month-old tg CSF ( Figure 1B) . Using a conventional ELISA that recognizes all Ab 1-x species including monomers, we confirmed that the tg mouse ISF and CSF indeed contained ample amounts of Ab ( Figure S1C ). We excluded the possibility that molecules in ISF or CSF interfere with the o-ELISA technique, as spiking these CNS fluids with low amounts of pure S26C Ab dimers gave positive signals in the expected range (Figure 1B) . We next eluted ISF of 3-and 20-month-old tg mice off a Superdex 75 size exclusion chromatography (SEC) column and subjected the resultant SEC fractions to a triplex ELISA that can detect low-femtogram amounts of endogenous Ab 38 , Ab 40 , and Ab 42 (detection antibody: 6E10). Whereas SEC fractions 14-16 in which Ab monomers elute (i.e., the $4 kDa fractions) gave abundant signals for all three Ab peptides, fractions 12 and 13 in which dimers elute (i.e., the $8 kDa fractions [Figure S1D] ) yielded no detectable signal above background from ISF at either age ( Figures 1C and 1D ). We confirmed that the Ab triplex ELISA is capable of detecting SEC fractions of synthetic dimers and monomers to commensurate degrees (Figures S1D and S1E). Collectively, these results from multiple sensitive biochemical assays-IP/WB, o-ELISA, and SEC followed by ultrasensitive Ab triplex ELISA-suggest that steady-state levels of LMW Ab oligomers in brain ISF or CSF of J20 tg mice are very low and thus below the detection limits of the methods used here.
Ab Oligomers Are Rapidly Sequestered Away from Hippocampal ISF In Vivo In light of this failure to detect significant amounts of LMW oligomers in brain ISF and CSF, we asked whether the half-life of Ab oligomers in ISF is much shorter than that of monomers. We acutely administered exogenous Ab dimers or monomers into hippocampal ISF of behaving WT mice using a cannula attached to the microdialysis probe. To distinguish the acutely administered Ab from endogenous Ab, we injected Ab of human sequence into ISF of WT mice and quantified the recovery of injected human Ab in ISF microdialysates using Ab 1-x ELISA, which recognizes human but not mouse Ab. As our monomer source, we used WT Ab 1-40 monomers, and as the Ab dimer-rich source, we used the S26C dimer, which was almost all dimeric and stayed as such throughout the time of our in vivo microdialysis ( Figures S2A and S2B ). We first empirically determined the concentrations of monomers and dimers that would allow equal percentages of these species to flow across the microdialysis membrane in vitro; the concentrations turned out to be 8 nM for monomers and 40 nM for dimers (see Supplemental Experimental Procedures; Figure S2C ). In stark contrast to these in vitro test-tube experiments in which the recoveries of Ab dimers and monomers were equivalent (Figure 2A) , the in vivo recovery of the injected dimers in the ISF dialysate was <10% of that of the injected monomers ( Figure 2B ). This large difference in the relative recoveries of Ab dimers versus monomers between in vitro (102% ± 11.4%) and in vivo (8.9% ± 2.8%) microdialysis was highly significant (p < 0.0001) ( Figure 2C) . Importantly, the disappearance of the injected Ab dimers from WT ISF occurred rapidly ( Figure 2D ). The low recovery of injected Ab dimers versus monomers in the ISF was not due to a general limit on in vivo diffusion, nor did we obtain evidence of acute perturbations of several non-Ab analytes in the respective microdialysates ( Figures S2D-S2F ). The rapid disappearance of Ab oligomers from brain ISF was confirmed using microinjection of a second source of synthetic Ab dimers, namely, noncrosslinked WT dimers ( Figures S2H and S2I ).
Ab Dimers Injected into Hippocampal ISF In Vivo Are Principally Recovered in the Membrane Fraction as Monomers Bound to GM1 Ganglioside To follow the fate of Ab oligomers released into ISF, we injected Ab dimers or monomers in low, endogenous amounts (320 pg) into the hippocampal ISF of WT mice and immediately (<1 min) sacrificed the mice for brain fractionation. The cytosolic/extracellular (TBS) and membrane-associated (TBS with 1% Triton X-100 [TBS-Tx]) fractions were promptly immunoprecipitated for human Ab. A much higher percentage of the injected Ab was immunoprecipitated from brain membrane fractions of the dimer-injected mice than those of the monomer-injected mice ( Figures 2E and 2F ). Surface biotinylation experiments in intact primary hippocampal neurons demonstrated the surface retention of Ab dimers, but not monomers, on the neuronal plasma membrane; this surface binding occurred prior to lysing the biotinylated cells ( Figure S3A ). The latter finding, together with the rapid sequestration of Ab dimers away from ISF and to the brain membrane fraction (Figure 2 ), suggests that Ab dimers bind cellular membranes more avidly than monomers do and may explain their very low or undetectable levels in CNS fluids (ISF and CSF) at steady state.
In contrast to the in vitro microdialysis experiments in which Ab dimers remained stable as dimers for 24-36 hr ( Figure S2B ), the Ab S26C dimers we injected into ISF in vivo were recovered as reduced monomers in both the ISF microdialysates (1 hr after injection) ( Figure S2G ) and the brain TBS and TBS-Tx fractions ( Figures 2E and 3A , see S26C 320 pg in vivo), except when a much higher concentration of Ab S26C dimers was injected (Figure 3A, see S26C 320 ng in vivo) . The conversion of the disulfide crosslinked synthetic dimers to monomers when injected in vivo could be explained by the brain providing a reducing environment. We therefore decided to isolate natural Ab dimers directly from TBS cortical extracts of typical AD brains using SEC (Shankar et al., 2008) and injected these human Ab dimers into the ISF (B) ISF of 3-month-old tg (n = 4 mice) and 20-month-old tg (n = 7 mice) and CSF of 3-month-old tg (n = 7 mice) were assayed using Ab o-ELISA. Sensitivity and specificity of o-ELISA were tested using tg ISF and CSF spiked with low levels of synthetic Ab dimers or monomers and 20-month-old tg TBS extract and its corresponding 3D6 Ab-immunodepleted sample. (C and D) We loaded 250 ml hippocampal ISF from 3-month-old tg (C) and 20-month-old tg (D) onto Superdex 75 SEC column and resultant fractions were subjected to 6E10 Ab triplex ELISA. Value = normalized mean ± SEM; n = 3 mice each. Dotted lines indicate where synthetic Ab dimers and monomers were eluted using the same SEC column. See also Figure S1 . of WT mice. Even this largely dimeric material was recovered by IP/WB from the brain homogenates as 4 and 5 kDa Ab monomers ( Figure 3A , see huAD TBS dimers in vivo). Almost all of the injected Ab dimers (whether synthetic or from human brain) were recovered in the TBS-and TBS-Tx-soluble extracts ( Figure 3A) , and none was recovered in the TBS-Tx-insoluble pellets (data not shown); the latter suggests that the injected dimers did not accumulate into large insoluble aggregates during the short time course of our experiment.
Intriguingly, whereas the injected Ab immunoprecipitated from TBS extract ran at the size of monomers (4 kDa), the injected Ab immunoprecipitated from TBS-Tx extract ran slightly higher as a 5 kDa species ( Figure 3A , see S26C 320 pg in vivo and huAD TBS dimers in vivo). Based on a prior report of a GM1 gangliosidebound form of human Ab monomer occurring as a 5 kDa species in diffuse plaque-rich cortex of early AD or Down syndrome (DS) cases (Yanagisawa et al., 1995) , we probed the microinjected, immunoprecipitated Ab species with the b-subunit of cholera toxin (CTb), which specifically binds GM1 ganglioside (van Heyningen, 1974) . The immunoprecipitated 5 kDa Ab species recovered from the TBS-Tx extract was reactive with CTb, indicating that the Ab in the membrane fraction was bound to GM1 ganglioside ( Figure 3B , first and fifth panels). High-resolution imaging of the hippocampal CA1 region of such WT mouse that received in vivo Ab injection demonstrated that most of the retained Ab was colocalized with endogenous GM1 ganglioside ( Figure S3B ). This result on brain sections suggests that the association of GM1 with Ab occurs in vivo, that is, it can be seen without tissue homogenization. Likewise, the above-mentioned surface biotinylation of Ab on intact neurons ( Figure S3A ) supports this conclusion. Importantly, we failed to recover the 5 kDa Ab species when we performed the acute Ab injections into mice lacking gangliotetraose gangliosides (i.e., with a disrupted gene for GM2/GD2 synthase [Sheikh et al., 1999] ), thus providing confirmatory evidence that the 5 kDa Ab species is GM1 gangliosidebound Ab ( Figure S3C ). Interestingly, we did not observe a 5 kDa GM1-bound Ab species when we spiked the Ab S26C dimers ex vivo into postmortem WT mouse brain homogenates ( Figure 3 , see 320 pg ex vivo), suggesting that the binding of Ab to endogenous GM1 on membranes required the intact environment of the living brain. Furthermore, when we injected a high level of Ab S26C in vivo, we recovered from the TBS-Tx fraction the Ab S26C as intact dimers bound to GM1, namely, an $10 kDa CTb-positive Ab species (Figures 3A and 3B, see 320 ng in vivo) .
In 
Ab Oligomers Preferentially Bind to GM1 Ganglioside
We next performed isothermal titration calorimetry (ITC), measuring Ab binding to or incorporation into lipid membranes by detection of concomitant heat release (Seelig, 2004) . To use ITC to quantitatively assess membrane binding in vitro, we titrated suspensions of small unilamellar vesicles composed of POPC/GM1 (9:1) into freshly prepared Ab S26C dimer solutions and measured the observed heat release via ITC. Analysis of the partition equilibrium revealed an apparent binding constant Kp of the Ab S26C interaction with GM1 of $10,000 M À1 per lipid molecule bound ( Figure 4A ). As a control for the specificity of the interaction of Ab S26C with GM1, we repeated the ITC experiments titrating suspensions of either pure POPC or POPC/SM (9:1) into Ab S26C dimer solutions. These experiments yielded no detectable heat release during the titration, indicating a lack of interaction between Ab S26C and POPC alone or POPC plus sphingomyelin ( Figure 4A ). Similar negative results were obtained upon titrating POPC/GM1 into solutions of either WT Ab40 monomer or Ab S26C solutions with reducing agent (1% bME) present (i.e., monomers) ( Figure 4B ). These ITC experiments suggest that the dimeric state of the Ab protein binds GM1 much more avidly than the monomeric state and that the monosialotetrahexosyl head group of GM1 may be necessary for efficient Ab binding to lipid membranes, at least in vitro.
Blocking the GM1 Sialic Acid Moiety Prevents Ab Oligomer-Mediated LTP Impairment
We asked whether the binding of Ab dimers to GM1 ganglioside has functional consequences, that is, whether it plays a role in the known ability of the dimers to potently inhibit long-term potentiation (LTP) (Li et al., 2011; Shankar et al., 2008) . The sialic acid of GM1 has been shown to be required for the in vitro binding of Ab to GM1 (Ariga et al., 2001; Choo-Smith et al., 1997; McLaurin and Chakrabartty, 1996) . We therefore asked whether masking the sialic acid with CTb, which binds to the two terminal sugars of GM1 including sialic acid (Merritt et al., 1994) , may interfere with the binding of Ab oligomers to GM1 in hippocampal slices and thus reveal any functional consequences of the binding. At a dose (0.4 mM) at which CTb by itself caused a slight decrease of LTP magnitude in WT mouse hippocampal slices (140% ± 6%, n = 8; Figure 5A , blue circles), pretreatment with CTb fully prevented the impairment of hippocampal LTP by soluble S26C Ab dimers (153% ± 3%, n = 9, green triangles) (Figure 5 ). These data suggest that the binding of Ab oligomers to GM1 ganglioside plays a required role in mediating Ab-induced synaptic dysfunction.
Endogenous Ab, Particularly Ab 42 , Is Complexed to GM1 Ganglioside on Membranes of Young hAPP Transgenic Mice We next asked whether endogenous Ab occurs in a complex with GM1 ganglioside on brain membranes. Using an Ab antiserum (R1282), we immunoprecipitated the brain TBS-Tx extracts of 3-month-old J20 tg, 20-month-old J20 tg, or non-tg littermate mice and found that the TBS-Tx extracts of the plaque-free 3-month-old tg mice contained CTb-positive GM1-bound Ab ( Figure 6A ). In contrast, the plaque-rich 20-monthold tg contained very little GM1-bound Ab in the membrane extract despite having far more total Ab ( Figure 6A ). We failed to detect other brain lipids such as galactocerebroside (GCB) or phosphatidylethanolamine (PE) in the Ab immunoprecipitates of 3-month-old tg TBS-Tx ( Figure S4B ). Moreover, thin-layer chromatography of the R1282 Ab immunoprecipitates showed lack of enrichment in the major brain lipids detectable by the lipid dye primulin ( Figure S4C ), whereas the Ab immunoprecipitate of the 3-month-old tg TBS-Tx (but not that of the non-tg) yielded a CTb-positive spot ( Figure S4D ). Next, we took advantage of a monoclonal antibody (4396C) specifically raised against GM1-bound Ab isolated from membrane fractions of human brains rich in diffuse plaques (Hayashi et al., 2004 ; Yanagisawa et al., We injected 320 pg or 320 ng synthetic S26C Ab dimers, huAD TBS dimers, or buffer (mock) to anesthetized WT mice, then the brains were immediately harvested for brain fractionation. The in vivo injected brain fractions (TBS and TBS-Tx extracts) or S26C Ab spiked ex vivo to extracts or to buffer alone were immunoprecipitated for Ab using R1282. WB: 3D6+6E10 for Ab (A) or CTb for GM1 (B). Representative blots of n = 5, 3, 5, and 5 mice for 320 pg S26C, 320 ng S26C, mock, or huAD TBS dimer injections, respectively. See also Figure S3 .
1997). We confirmed that 4396C immunoprecipitates neither Ab nor GM1 alone ( Figure S4A ) but that it immunoprecipitates the GM1-bound Ab complex from 3-month-old tg TBS-Tx, leaving behind in the supernatant an Ab species that is not CTb positive, as recovered by a subsequent R1282 IP ( Figures 6B and S4A) . The 4396C immunoprecipitate from 3-month-old tg TBS-Tx contained a CTb-positive 5 kDa Ab species ( Figure 6B , lane 1) with a characteristic cap-like shape akin to that of the 5 kDa Ab from WT TBS-Tx that received in vivo Ab injection ( Figures 2E  and 3) . As in the R1282 Ab immunoprecipitates of 20-monthold tg TBS-Tx ( Figure 6A ), 4396C brought down very low levels of CTb-positive 5 kDa Ab from these old, plaque-rich animals (Figures 6B). Using C-terminal-specific Ab antibodies for IP, we found substantially more Ab 42 than Ab 40 to be GM1 ganglioside bound, despite there being comparable levels of total Ab 40 and Ab 42 recovered from the membrane extracts of 3-month-old tg ( Figures 6C and 6D) . Collectively, these various findings in J20 tg mice support the hypothesis that more hydrophobic Ab species (oligomers > monomers; Ab 42 > Ab 40 ) are sequestered onto neuronal membranes, primarily onto GM1 ganglioside. In contrast to the Ab acute microinjection experiments in 3-month-old WT mice, where most of the exogenous Ab was recovered as bound to GM1 ganglioside in the membrane extracts (Figure 3 ), a smaller portion of endogenous Ab ($5%-30%) was recovered as bound to GM1 ganglioside in the 3-month-old J20 tg brains ( Figures 6B and S4D) . Furthermore, the higher recovery of endogenous GM1-bound Ab in 3-month-old tg brain (preplaque, high ISF Ab 42 ) versus 20-month-old tg brain (plaque-rich, low ISF Ab 42 ) may be associated with the levels of available ISF Ab at these two ages (Hong et al., 2011) . To assess whether it is predominantly the endogenous Ab that is actively released into the ISF that binds GM1, we treated the 3-month-old tg mice with Compound E, a strong inhibitor of g-secretase that induces a rapid decline in brain ISF Ab (t 1/2 of $2 hr) (Hong et al., 2011) . Compound E decreased the levels of GM1-bound Ab in the 3-month-old tg TBS-Tx in a manner comparable to its reduction of ISF Ab levels ( Figures 6E and  6F ), suggesting that there is a rapid equilibrium between soluble (ISF) and membrane-bound (TBS-Tx) pools of Ab. We confirmed that Compound E had no effect on total GM1 levels in the brain (data not shown). Collectively, all of the results in this section suggest that newly generated Ab, and especially Ab 42 , upon being released into the extracellular fluid (i.e., ISF), readily binds to GM1 ganglioside on adjacent membranes, and this can apparently occur early in the AD pathogenic process, i.e., before plaques form. Finally, whereas we recover dimers in the 20-month-old tg TBS-Tx, they do not seem to be associated with GM1, as evidenced by the negative CTb blotting in the R1282 Ab immunoprecipitates ( Figure 6A ). The dimers that we observe in the TBS-Tx extract of plaque-rich 20-month-old tg may not necessarily be associated with membranes per se but may represent Ab oligomers that are extracted from plaques during tissue homogenization in TBS-Tx (Hong et al., 2011) .
GM1-Bound Ab Is Detectable in Human CSF and Correlates with CSF Ab 42 Levels
Using the 4396C antibody that is specific for the GM1-Ab complex ( Figure S4A ), we recovered a soluble GM1-bound Ab species in cognitively normal human CSF (n = 10 samples), as evidenced by positive reaction for Ab and GM1 (CTb+) at the $4.5-5 kDa position ( Figure 7A , 4396C IP/Ab WB first, then stripped and blotted with CTb; Figure 7B , 4396C IP directly blotted with CTb). The levels of GM1-bound Ab in human CSF showed a significant direct correlation (r 2 = 0.72) with levels of Ab 42 in the same CSF samples ( Figures 7C and 7D ) and to a lesser but still significant degree (r 2 = 0.49) with levels of Ab 40
( Figure 7E ).
DISCUSSION
Despite the extensive genetic and biochemical evidence for a pathogenic role of soluble Ab oligomers in the most common cognitive syndrome of late life, our understanding of the dynamics of Ab oligomers in the CNS in vivo is limited. To address key mechanistic and biomarker-related questions of whether Ab oligomers are present in biological fluids and the nature of their dynamics, we first searched for oligomers in the two CNS aqueous compartments, ISF and CSF, of tg mice that express (A) Suspensions of POPC/GM1 (9:1), POPC/ sphingomyelin (SM) (9:1), or pure POPC small unilamellar vesicles at 40 mM were titrated into freshly prepared Ab S26C dimer solutions (15 mM) and subsequent heat release was measured. The hyperbolic shape of the titration curve in case of POPC/GM1 (9:1) indicates a partition equilibrium of Ab S26C dimers into the lipid membrane, while titrations of POPC/SM (9:1) or pure POPC vesicles yielded no detectable heat release.
(B) Titrating suspensions of POPC/GM1 (9:1) into solutions containing WT Ab40 monomers or Ab S26C with 1% bME present (i.e., reduced monomers) yielded no detectable heat release during the titration when compared to Ab S26C dimers. Representative of three experiments each using two different preparations of Ab S26C and vesicles.
substantial levels of hAPP and undergo progressive AD-like cerebral deposition of human Ab. Despite combining three sensitive biochemical methods, IP-WB, o-ELISA, and SEC followed by triplex ELISA, we failed to detect substantial levels of soluble LMW (<35 kDa) Ab oligomers in hippocampal ISF or CSF of this AD mouse model. These results are consistent with two previous ELISA reports that failed to detect Ab oligomers in human CSF (Esparza et al., 2013; Yang et al., 2013) , one of which used two highly specific Ab o-ELISAs in samples of CSF from 90 humans (including elderly subjects with either presymptomatic or early clinical AD) . Based on these studies and the current work, we conclude that the steady-state levels of LMW Ab oligomers in the brain's aqueous compartments are very low (<0.02% of total CSF Ab levels) and thus below the detection limits of the specific methods used here.
To explore this dearth of soluble oligomers mechanistically, we performed in vivo Ab microinjection experiments into the hippocampal ISF of WT (plaque-free) mice and observed far lower recovery of injected dimers than of injected monomers, raising the hypothesis that soluble Ab dimers released into the extracellular space are unlikely to remain very long in aqueous fluids. In accord, their relative hydrophobicity appeared to drive the sequestration of the dimers away from the extracellular fluid and onto local membranes. A much higher proportion of the injected dimers was recovered in the membrane (TBS-Tx) extract than in the soluble (TBS) fraction of the brain. Surface biotinylation experiments on intact hippocampal neurons and a quantitative in vitro binding assay using isothermal calorimetry likewise demonstrated that Ab oligomers bind membranes much more avidly than Ab monomers do. We therefore conclude that any newly generated and released Ab oligomers may be rapidly sequestered from the extracellular fluid (ISF) onto plasma membranes of surrounding cells in the brain parenchyma.
In mimicking newly formed Ab oligomers in the brain, the in vivo injected dimers rapidly became membrane bound, in contrast to the monomers. Intriguingly, both synthetic dimers and natural dimers isolated from human AD cortex that were injected at low levels into WT mouse ISF were recovered in membrane extracts as monomers bound to GM1 ganglioside, thus shifting their electrophoretic migration to $5 kDa. This, along with the ITC binding assays and the microinjection experiments in GM1 knockout (KO) mice, suggests a relative propensity for Ab dimers to bind to GM1-containing lipids on membranes. This realization led us to use pan-Ab, C-terminal-specific, and GM1-Ab-specific antibodies to probe Ab species in a hAPP tg mouse model, and we observed substantial levels of endogenous GM1-bound Ab, in particular the Ab 42 peptide, in the brain membrane fraction at an early age (3 months), before plaques form in this model. This result is reminiscent of an earlier study showing that Ab 42 can be found associated with GM1 ganglioside in the brains of AD and DS subjects who had abundant diffuse plaques but little to no mature plaques or neurofibrillary tangles (Yanagisawa et al., 1995) . The disassociation of dimers to monomers (unless given at high ng levels) seems to occur after the dimers bind to membranes, as suggested by both the surface biotinylation experiment in primary hippocampal neurons and the ITC. The use of a covalently crosslinked form of Ab oligomers would be insightful to further understand this process. In addition, it would be interesting to measure the half-life and fate of oligomers in brains already having very abundant Ab plaques, as we previously did with the monomers (Hong et al., 2011) .
To date, we have failed to detect an enrichment of other brain lipids bound to Ab in our assays, including certain phospholipids, ceramides, and phosphosphingolipids that we probed for. Moreover, preliminary data using GM2/GD2 synthase KO mice suggested a possible gene-dosage effect of GM1 in mediating the sequestration of Ab dimers onto membranes: the less GM1 the brain had, the lower the percent of injected Ab dimers we recovered from the membrane fraction (data not shown). However, caution is needed in using this mouse model, as these mice now have robustly increased levels of GM3 and GD3 in the CNS (Wu et al., 2001 ); GM3 has also been shown in vitro to bind to and facilitate the aggregation of Ab (Ariga et al., 2001; Grimm et al., 2012; Yahi et al., 2010; Yamamoto et al., 2005) . Given these confounding factors, we do not regard this GM1 KO model as ideal for the study of Ab effects. It is important to emphasize that although our data using an array of techniques uncover a preferential binding of Ab oligomers to GM1 gangliosides and that this Ab-GM1 binding survives denaturation by SDS and heat, there may well be other lipid targets to which Ab binds. Lipidomic mass spectrometry is currently being pursued to examine various lipid candidates. The key finding that we can recover a GM1-Ab complex in fresh human CSF samples suggests that the GM1-Ab complex exists in vivo in the human brain (i.e., in the absence of tissue homogenization) and that it reaches the CSF in small amounts. Likewise, immunohistochemistry of mouse brain sections after in vivo Ab injection showed that the remaining injected Ab was principally colocalized with endogenous GM1 ganglioside, again eliminating tissue homogenization as an artifactual reason for this association. Finally, the spiking of Ab oligomers into postmortem brain membrane extracts ex vivo failed to induce binding of the exogenous Ab to endogenous GM1 gangliosides, suggesting that the formation of the GM1-Ab complex we recover both in WT in vivo microinjection studies and in hAPP tg mice requires the environment of the intact living brain. (A) S26C dimers (10 nM) alone blocked LTP induction (129% ± 6%, n = 12, red inverted triangles) compared to vehicle alone (aCSF) (159% ± 6%, n = 12, black squares). Whereas CTb (0.4 mM) alone slightly decreased LTP (140% ± 6%, n = 8, blue circles), it fully restored the S26C dimer-impaired hippocampal LTP (153% ± 4%, n = 9, green triangles). n = slices. (B) The effect of S26C alone versus S26C on slices pretreated with CTb is compared. Value = mean ± SEM at 55 min of LTP induction. ***p < 0.0001 by two-tailed Student's t test.
Individual laboratories have reported various potential protein receptors for Ab oligomers, including a7 nicotinic receptors, NMDA, mGluR, and AMPA receptors, insulin receptors, PrP c , and LilrB2/PirB (De Felice et al., 2007 Kim et al., 2013; Lauré n et al., 2009; Wang et al., 2000; Zhao et al., 2010) . Although it is possible that Ab oligomers bind to specific cellsurface proteins such as these and that this stabilizes their presence on the plasma membrane, the amphipathic hydrophobicity of the self-aggregating Ab 42 peptide suggests a biochemically more plausible scenario: that the hydrophobic Ab 42 oligomers released into the extracellular fluid (ISF) become rapidly sequestered onto hydrophobic surfaces of adjacent lipid membranes. Our data here suggest that GM1 ganglioside could be a principal lipid target of Ab 42 oligomers early in the course of AD-type b-amyloidosis. Gangliosides are particularly enriched in the nervous system compared to other tissues, and the subcellular localization of GM1 has been mapped out to be mostly in ''raft-like domains'' enriched in cholesterol and sphingomyelin on plasma membranes of neuronal processes, including pre-and postsynaptic membranes, and on certain lipid vesicles such as exosomes (Hansson et al., 1977; Pernber et al., 2012; Sonnino et al., 2007; Svennerholm and Gottfries, 1994 tions of GM1 and to a lesser extent GM2 have been reported to be increased in detergent-resistant membranes from frontal cortices of early AD brains (Molander-Melin et al., 2005) and the Ab-GM1 complexes were found in the cortical neuropil and not on amyloid plaques per se in early AD and DS brains (Hayashi et al., 2004) . Both our in vivo ISF studies and in vitro ITC binding data indicate that Ab dimers can rapidly and avidly associate with GM1-containing lipid membranes. We note that hydrophobicity alone may not be the key factor for the Ab oligomers' preferential binding to GM1, in particular given our current ITC data and previous in vitro reports that the negatively charged sialic acid of gangliosides may be a prime binding site (Ariga et al., 2001; Choo-Smith et al., 1997; McLaurin and Chakrabartty, 1996) .
Collectively, our results elucidate the complex economy of newly secreted Ab oligomers as regards their membrane association and progressive loss of solubility over time. Our findings here help explain the apparently very low levels of Ab oligomers as soluble, freely diffusible species in ISF and CSF at steady state in vivo, and they support the hypothesis that due to their increased hydrophobicity, Ab 42 oligomers primarily bind to GM1 ganglioside (and potentially other surface lipids) on neuronal membranes. Blocking the specific GM1 receptor site using CTb rescues the well-documented impairment of hippocampal LTP by Ab oligomers, suggesting that the binding of Ab to GM1 may be a step that leads to downstream synaptotoxic effects of Ab. Thus, Ab, upon binding to GM1 ganglioside, may then mediate subtle but progressively detrimental biophysical alterations of neuronal membranes-for e.g., by disrupting membrane fluidity or ion permeability-and thus lead secondarily to aberrant function and turnover of a variety of transmembrane receptors.
Finally, we show that a GM1-bound Ab species can be detected, albeit in low amounts, in human CSF and that its levels are significantly correlated with the levels of Ab 42 (and less so of Ab 40 ). Reduced CSF levels of Ab 42 in subjects with presymptomatic or early AD are a widely validated biomarker of the disease process, and these levels appear to relate inversely to amyloid plaque burden, degree of brain atrophy, and severity of cognitive deficits in humans (Bateman et al., 2012; Fagan et al., 2009; Motter et al., 1995; Shaw et al., 2009) . Interestingly, there has been a report of increased GM1 gangliosides in the CSF of AD patients versus healthy controls (Blennow et al., 1991) ; however, the level of total gangliosides may not necessarily reflect the portion of Ab-bound GM1. Accordingly, it will now be important to examine whether the GM1-bound Ab complexes in CSF we describe could serve as an early biomarker in presymptomatic subjects, especially in light of the challenges of quantifying Ab oligomers in CSF.
EXPERIMENTAL PROCEDURES Animals
All animal procedures were approved by the Harvard Medical School Institutional Animal Care and Use Committee. See Supplemental Experimental Procedures for details.
In Vivo Microdialysis
Microdialysis was performed in the hippocampus of awake and normally behaving mice housed in a ''Raturn'' cage system (Bioanalytical Systems) as previously described (Cirrito et al., 2003; Hong et al., 2011) . We perfused 1.5% bovine serum albumin in artificial CSF (1.3 mM CaCl 2 , 1.2 mM MgSO 4 , 3 mM KCl, 0.4 mM KH 2 PO 4 , 25 mM NaHCO 3 , and 122 mM NaCl [pH 7.35]) using BR-2 probes with 35 kDa MWCO membranes (Bioanalytical Systems) at 0.2 or 0.4 ml/min using an infusion syringe pump (Stoelting).
Mouse CSF Collection CSF was collected from cisterna magna of deeply anesthetized mice (DeMattos et al., 2002) . Midline incision was made from top of the skull to dorsal thorax, followed by excision of muscles and excess tissue from base of the skull to first vertebrae. A small hole was made to arachnoid membrane covering the cistern using tip of 29G one-half inch needle and CSF exiting compartment was collected using a gel-loading pipet.
Half-Life Studies of Ab in ISF In Vivo
We injected 3 ml of 8 nM Ab monomers or 40 nM dimers into the hippocampus of adult C57BL6xDBA2 mice through a combination infusion cannula and microdialysis probe (IBR-2, Bioanalytical Systems) at 0.2 ml/min. ISF was collected hourly at 0.4 ml/min, paused during the injection, then restarted 1 min after injection. ISF was analyzed for levels of Ab by Ab 1-x ELISA or o-ELISA or for levels of lactate, pyruvate, urea, and glucose (Yale Center for Clinical Investigation).
Intracortical Injection of Ab
Synthetic Ab or natural Ab isolated from AD cortex (1-2 ml volume) was injected at 0.5 ml/min via a Hamilton syringe into left hippocampus of anesthetized mice (Hong et al., 2011) . Mice were sacrificed <1 min after end of injection for biochemical analysis. (D and E) Levels of GM1-bound Ab recovered using 4396C in ten human CSF samples showed a strong correlation to their levels of Ab 42 (D; 21F12/3D6B ELISA) and less but still significant to levels of Ab 40 (E; 2G3/3D6B ELISA).
Mouse Brain Sample Preparation for Biochemical Analyses
Brains were homogenized using a mechanical Dounce homogenizer with 20 strokes at 4,000 rpm in ice-cold TBS (20 mM Tris-HCl, 150 mM NaCl [pH 7.4]) and protease inhibitors at 4:1 TBS volume:brain wet weight. Homogenate was centrifuged for 30 min at 175,000 3 g in a 4 C TLA100.2 rotor on Beckman TL100 (resulting supernatant = ''TBS extract''). Pellet was homogenized in ice-cold TBS with 1% Triton-X (TBS-Tx) and protease inhibitors at 4:1 TBS-Tx volume:brain wet weight and centrifuged for 30 min at 175,000 3 g in a 4 C TLA100.2 rotor (resulting supernatant = ''TBS-Tx extract''). TBS-Tx pellet was incubated with 88% formic acid at RT for 2 hr and lyophilized (''FA extract'').
Immunoprecipitation and Western Blot for Ab and GM1 Ganglioside IP/WB was performed as previously described with minor modifications (Walsh et al., 2000) . See Supplemental Experimental Procedures for details.
Ab ELISA Sandwich ELISAs for Ab were performed using the MULTI-ARRAY 96-well Plate platform (MesoScale Discovery) as described previously (Hong et al., 2011; Yang et al., 2013) . See Supplemental Experimental Procedures for details.
Size-Exclusion Chromatography ISF sampled at 0.4 ml/min (250 ml) or synthetic Ab (2 ng) were eluted at 0.5 ml/min from a Superdex 75 10/300GL column (GE Healthcare) with 50 mM ammonium acetate (pH 8.5). Resulting 1 ml fractions were lyophilized and then reconstituted in 60 ml perfusion buffer and analyzed using 6E10 Ab Triplex ELISA. For WB analysis, samples were subjected to WB using 3D6 and ECL Plus WB Detection Reagent.
Preparation of Ab Isolated from AD Cortex
Ab from TBS extract of human AD cortical tissue was prepared as previously described . Briefly, frozen temporal or frontal cortex samples were dissected and then homogenized as described above for mouse brain sample preparation. TBS extract was then subjected to IP with 3D6 (Elan, plc) and the Ab immunoprecipitate was eluted from a Superdex 75 SEC column in 50 mM ammonium acetate (pH 8.5). The SEC elution profile for Ab was verified by SDS-PAGE. The corresponding fractions where Ab dimers were eluted were used for the injection studies.
Isothermal Titration Calorimetry
For ITC, a Microcal ITC-200 instrument with a motor-driven syringe was used. Volume of the cell was 204 ml. Small volumes of small unilamellar vesicles, obtained by sanitation (40 mM total lipid), were injected into the protein solution (15 mM) of calorimetry cell at 20 C. Buffer used was 25 mM ammonium bicarbonate (pH 8.4) with 1 volume % b-mercapto ethanol added in case of the S26C monomer titrations. Monomeric or dimeric forms of Ab used for experiments were freshly eluted off a Superdex 75 SEC column and the corresponding fractions were kept on ice before use. For the experiments, 19 injections of 2 ml were used, after a preinjection of 0.4 ml to account for diffusion of titrant from the syringe. Integration of the heat signals and correction of the base line was done in Microcal Origin 5.0. Control titrations of lipid suspension into buffer alone were subtracted from the experimental data. The apparent partition constant was calculated from the initial heat signals where the equilibrium seems to be independent from electrostatic interaction between the protein molecules (Seelig, 1997) .
Electrophysiology on Acute Hippocampal Slices
Hippocampal slices were prepared as previously described (Li et al., 2013) . Briefly, 350-mm-thick transverse slices from hippocampus of 6-to 8-weekold C57BL/6x129 were incubated for >90 min in aCSF containing 124 mM NaCl, 2 mM KCl, 2 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 26 mM NaHCO 3 , 10 mM D-glucose [pH 7.4], and 310 mM mOsm and then were submerged beneath continuously perfused aCSF saturated with 95% O 2 and 5% CO 2 for stimulation at room temperature ($24 C). For electrophysiology, standard field excitatory postsynaptic potentials were recorded in the CA1 region of hippocampus as previously described (Li et al., 2013) . Briefly, stimulating electrode was placed in Schaffer collaterals to deliver test and conditioning stimuli, and borosilicate glass recording electrode filled with aCSF was positioned 200-300 mm from the stimulating electrode in stratum radiatum of CA1. To induce LTP, we applied two consecutive trains (1 s) of stimuli at 100 Hz separated by 20 s, a protocol that induces LTP lasting $1.5 hr in WT mice of this genetic background, to the slices. The field potentials were amplified 1003 using Axon Instruments 200B amplifer and digitized with Digidata 1322A. The data were sampled at 10 kHz and filtered at 2 kHz. Traces were obtained by pClamp 9.2 and analyzed using the Clampfit 9.2.
Human CSF Samples CSF samples were provided by Dr. Reisa Sperling (BWH) under institutional review board-approved protocols. Briefly, CSF was collected in polypropylene tubes using lumbar puncture and then spun at 400 3 g for 10 min; aliquots of the crystal-clear supernatant were stored at À80 C.
Statistical Analysis
Data was analyzed using PRISM (Graphpad Software) for one-way or two-way ANOVA followed by Bonferroni post hoc test if means were significantly different by ANOVA, or by two-tailed Student's t test, as appropriate.
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